Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL USE OF SULFORAPHANE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
Document Type and Number:
WIPO Patent Application WO/2021/115100
Kind Code:
A1
Abstract:
Provided are new use of sulforaphane for preparing a TFEB activator and for preparing drugs in the treatment and/or prevention of lysosomal storage diseases, and a pharmaceutical composition comprising same. It is confirmed that sulforaphane can promote the biosynthesis of lysosome and increase the activity of the lysosome by activating TFEB, so as to degrade storages in the lysosome. As sulforaphane has the described functions, it can be used for preparing drugs for treating and/or preventing lysosomal storage diseases.

Inventors:
LI DAN (CN)
XU HAOXIN (US)
Application Number:
PCT/CN2020/130447
Publication Date:
June 17, 2021
Filing Date:
November 20, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV ZHEJIANG TECHNOLOGY (CN)
UNIV MICHIGAN (US)
International Classes:
A61K31/26; A61P3/00; A61P35/00; A61P39/06
Domestic Patent References:
WO2020167822A22020-08-20
WO2012162535A12012-11-29
Foreign References:
CN111012773A2020-04-17
JP2018131429A2018-08-23
CN104640573A2015-05-20
CN103079545A2013-05-01
CN101120948A2008-02-13
Other References:
MEANEY STEVE, GRAY STEVEN G: "Epigenetic regulation of cholesterol homeostasis", FRONTIERS IN GENETICS, vol. 5, 24 September 2014 (2014-09-24), pages 1 - 10, XP055820301, DOI: 10.3389/fgene.2014.00311
Attorney, Agent or Firm:
PATENTSINO IP FIRM (CN)
Download PDF: